NewAmsterdam Pharma N.V.

NASDAQ: NAMSW · Real-Time Price · USD
13.80
0.00 (0.00%)
At close: Aug 15, 2025, 2:27 PM
13.80
0.00%
After-hours: Aug 15, 2025, 04:00 PM EDT

NewAmsterdam Pharma Revenue

NewAmsterdam Pharma reported an annual revenue of $45.56M, reflecting a undefined% growth. For the quarter ending June 30, 2025, NewAmsterdam Pharma generated $19.14M in revenue.
Revenue (ttm)
n/a
Revenue Growth
n/a
Price / Sales Ratio
n/a
Revenue / Employee
n/a
Employees
n/a
Market Cap
1.55B

Revenue Chart

Revenue History

Fiscal Year End Revenue % Change
Dec 31, 2024 45.56M +257.00%
Dec 31, 2023 12.76M -86.69%
Dec 31, 2022 95.91M +Infinity%
Dec 31, 2021 0 n/a
Dec 31, 2020 0 n/a
Sources: Historical revenue is based on company filings submitted to the U.S. Securities and Exchange Commission (SEC). The most recent revenue numbers may be taken from company press releases.